{"acne": 4.8, "blood pressure fluctuation": 12.31, "c-reactive protein increased": 2.38, "clostridium difficile infection": 10.45, "colitis": 13.72, "colitis ulcerative": 44.17, "condition aggravated": 5.11, "crohn's disease": 21.19, "cytomegalovirus colitis": 73.43, "cytomegalovirus infection": 8.65, "cytomegalovirus viraemia": 21.4, "decreased activity": 17.04, "diarrhoea haemorrhagic": 5.7, "disseminated tuberculosis": 50.37, "drug hypersensitivity": 2.96, "drug ineffective": 4.0, "drug ineffective for unapproved indication": 7.7, "drug intolerance": 5.04, "drug level above therapeutic": 26.77, "drug level decreased": 29.07, "drug specific antibody present": 49.46, "frequent bowel movements": 20.26, "haematochezia": 5.96, "haemophagocytic lymphohistiocytosis": 10.74, "heart rate decreased": 2.82, "hepatosplenic t-cell lymphoma": 413.23, "inappropriate schedule of product administration": 2.31, "incorrect product administration duration": 5.09, "infection": 2.04, "infusion related reaction": 3.74, "intentional product use issue": 4.64, "interstitial lung disease": 2.48, "intestinal obstruction": 3.99, "latent tuberculosis": 61.91, "loss of libido": 11.2, "lower respiratory tract infection": 4.03, "mouth ulceration": 6.14, "off label use": 4.48, "pancreatitis": 2.23, "pneumonitis": 4.37, "premature baby": 3.36, "product use in unapproved indication": 2.62, "product use issue": 6.96, "productive cough": 2.38, "psoriasis": 4.09, "pulmonary tuberculosis": 31.6, "rectal haemorrhage": 11.69, "septic shock": 2.29, "tachyphrenia": 48.85, "takayasu's arteritis": 170.43, "therapeutic product effect incomplete": 4.24, "therapeutic response decreased": 4.69, "therapy non-responder": 3.61, "treatment failure": 11.55, "weight decreased": 2.21, "weight increased": 4.08}